Identification of Respiratory Syncytial Virus Fusion Protein Inhibitor: In silico Screening and Molecular Docking Approach
Khalid Alshaghdali · Journal of Pharmaceutical Research International · 2021
In young children, immunocompromised individuals, and elderly people, the respiratory syncytial virus (RSV) is the primary source of acute lower respiratory tract infection. Intervention with RSV-specific small-molecule antivirals may provide significant therapeutic potential. Fo...
Open access
Research Article
10.9734/jpri/2020/v32i4731112